UG HEALTHCARE CORPORATIONLTD (8K7) Fair Value & Analysis
Healthcare · SG · Market cap 48.7M SGD
Fair value as of: Aug 13, 2026
From 4 valuation models · updated 4 days ago
Share price −11.4% over the past month.
A solid business, but screening 42% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (0.0485 SGD). The favourable scenario is already priced in.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder.
- A fairly wide model range (0.0254 SGD to 0.0485 SGD) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range 0.0700 SGD – 0.6750 SGD · fair‑value band 0.0254 SGD – 0.0485 SGD · the 0.0700 SGD price screens above the 0.0408 SGD fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
UG HEALTHCARE CORPORATIONLTD (8K7) currently trades at 0.0700 SGD, while our model-based Fair Value estimate is 0.0408 SGD, implying the stock looks roughly 41.7% overvalued today. The Quality Score stands at 54/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Over the trailing twelve months, UG HEALTHCARE CORPORATIONLTD generated revenue of 146M SGD at a net margin of -3.0%. Revenue grew 2.8% year over year. It earns a return on equity of -2.5%. Net debt stands at 23.5M SGD. Fundamentals as of Aug 13, 2026
Our scenario range runs from 0.0254 SGD (bear case) to 0.0485 SGD (bull case); at 0.0700 SGD, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 38% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -46% fair-value upside, at -42%, 8K7 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 4 models by family
Widest divergence: Asset-Based (0.1700 SGD) versus Dividend Discount (0.0400 SGD). Highest evidence: Gordon GGM (70).
Notify me when 8K7 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 53 · Market factors (momentum, volatility) 24
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
UG Healthcare Corporation Limited, an investment holding company, manufactures and sells disposable gloves. It operates through Latex Examination Gloves, Nitrile Examination Gloves, and Other Ancillary Products segments.
Full company description
UG Healthcare Corporation Limited, an investment holding company, manufactures and sells disposable gloves. It operates through Latex Examination Gloves, Nitrile Examination Gloves, and Other Ancillary Products segments. The company distributes ancillary products, including surgical, vinyl, and cleanroom disposable gloves and reusable gloves, as well as face masks, and other medical disposables. It serves customers under the Unigloves brand name in Europe, North America, South America, Africa, Asia, and internationally. UG Healthcare Corporation Limited was founded in 1989 and is based in Singapore.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
UG HEALTHCARE CORPORATIONLTD reported revenue of 144M SGD in FY2025 versus 338M SGD in FY2021, a compound −19.2%/yr. Reported net income was −3.8M SGD in FY2025.
8K7 screens 42% overvalued. Compare with Intuitive Surgical, Inc →
Peer Group
Medical Instruments & Supplies · 204 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Instruments & Supplies median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $401.27 | $150.04 | -63% |
| EssilorLuxottica Société anonyme 1EL | €164.40 | €68.55 | -58% |
| Medline Inc MDLN | $35.50 | $30.15 | -15% |
| Becton, Dickinson and Company BDX | $181.41 | $100.46 | -45% |
| Alcon Inc ALC | $73.58 | $39.78 | -46% |
| ResMed Inc RMD | $226.00 | $187.89 | -17% |
| West Pharmaceutical Services, Inc WST | $352.29 | $141.58 | -60% |
| Sartorius Stedim Biotech S.A DIM | €180.30 | €48.88 | -73% |
| Coloplast A/S COLOB | kr 429.70 | kr 382.22 | -11% |
| Gan & Lee Pharmaceuticals., a biopharmaceutical company, 603087 | ¥77.48 | ¥27.22 | -65% |
Compare UG HEALTHCARE CORPORATIONLTD with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is UG HEALTHCARE CORPORATIONLTD (8K7) overvalued or undervalued?
What is the fair value of 8K7?
What is the quality score of 8K7?
What is the revenue of UG HEALTHCARE CORPORATIONLTD (8K7)?
What is the net profit margin of 8K7?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track UG HEALTHCARE CORPORATIONLTD and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.